← back to search

Hideki Hasegawa

Institut de Recherche Vaccinale · FR
Area of research
Epidemiology · Electrical and Electronic Engineering
Research interest
Research interests include Influenza Virus Research Studies, Semiconductor materials and devices, Respiratory viral infections research, and SARS-CoV-2 and COVID-19 Research.
h-index
68
citations
18,566
works
594
NIH funding
primary concept
email

Recent publications

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection
bioRxiv (Cold Spring Harbor Laboratory) 2026cited by 1position: middledoi
Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses.
2026cited by 1position: contributordoi
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses.
2026cited by 0position: contributordoi
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025
Virus Evolution 2025cited by 4position: middledoi
Potent efficacy of a NA-targeting antibody against a broad spectrum of H5N1 influenza viruses
2025cited by 0position: contributordoi
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
eLife 2024cited by 22position: middledoi
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
eLife 2024cited by 15position: middledoi
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
eLife 2024cited by 1position: middledoi
When to update COVID-19 vaccine composition
Nature Medicine 2023cited by 50position: middledoi
When to update COVID-19 vaccine composition.
2023cited by 28position: contributordoi
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants
New England Journal of Medicine 2022cited by 323position: middledoi
Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
2020cited by 114position: contributordoi
Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
2020cited by 33position: contributordoi
CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses
Vaccine 2019cited by 17position: middledoi
Reducing the global burden of HTLV-1 infection: An agenda for research and action
Antiviral Research 2016cited by 145position: middledoi
Characterization of H7N9 influenza A viruses isolated from humans
Nature 2013cited by 404position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2020–2026)Shinji Watanabe · National Institute of Infectious Diseases5 papers (2022–2026)John Huddleston · Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa5 papers (2024–2026)Trevor Bedford · Fred Hutch Cancer Center4 papers (2024–2025)Ruth Harvey · The Francis Crick Institute4 papers (2024–2025)Nicola S. Lewis · National Influenza Center4 papers (2024–2025)Ian Barr · Icahn School of Medicine at Mount Sinai4 papers (2024–2025)Rebecca Kondor · Centers for Disease Control and Prevention3 papers (2024–2024)Burcu Ermetal · Centers for Disease Control and Prevention3 papers (2024–2024)Xiyan Xu · Institute of Atmospheric Physics3 papers (2024–2024)Seiichiro Fujisaki · National Institute of Infectious Diseases3 papers (2024–2024)C. Hansen · Roskilde University3 papers (2024–2024)Noriko Kishida · National Institute of Infectious Diseases3 papers (2024–2024)Thomas Rowe · Centers for Disease Control and Prevention3 papers (2024–2024)Rodney S. Daniels · The Francis Crick Institute3 papers (2024–2024)Sheena G. Sullivan · World Health Organization - Pakistan3 papers (2024–2024)John W. McCauley · The Francis Crick Institute3 papers (2024–2024)David E. Wentworth · Centers for Disease Control and Prevention3 papers (2024–2024)Amanda C. Perofsky · Northeastern University3 papers (2024–2024)Kazuya Nakamura · National Institute of Infectious Diseases3 papers (2024–2024)